Russell Investments Group
ORKA

Russell Investments Group’s Oruka Therapeutics ORKA Stock Holding History

Russell Investments Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Buy
112,943
+67,484
+148% +$4.5M 0.01% 1033
2026
Q1 		$2.23M Buy
45,459
+42,418
+1,395% +$1.47M ﹤0.01% 1826
2025
Q4 		$92.2K Buy
3,041
+788
+35% +$22K ﹤0.01% 3070
2025
Q3 		$43.3K Buy
+2,253
New +$33.4K ﹤0.01% 3347

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Russell Investments Group's ORKA Position: Q2 2026 in Review

Russell Investments Group increased its Oruka Therapeutics (ORKA) stake by 148% in Q2 2026, buying an estimated $4.5M and bringing the position to 112,943 shares worth $10.7M. The position accounts for 0.01% of the portfolio, ranked #1033.

Russell Investments Group first reported a position in ORKA in Q3 2025 and has held it in 4 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Russell Investments Group held 112,943 shares of Oruka Therapeutics worth $10.7M as of Q2 2026.
  • Russell Investments Group bought 67,484 Oruka Therapeutics shares in Q2 2026, an estimated $4.5M.
  • Oruka Therapeutics made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1033 holding.
  • Russell Investments Group first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.